All these data together suggest that the activation of IL-33 could be associated with a poor prognosis in liver fibrosis by the upregulation of type 2 immune response, leading to the increase in type 2 cytokines which are mainly the cause of biliary injuries and fibrosis. Here, IL33 is linked to Hepatic fibrosis.